BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 18, 2015
View Archived Issues
Astellas Pharma presents milestones of fourth quarter of fiscal 2014
Read More
Sun Biomedical agrees to acquire Dimerix Bioscience
Read More
Eisai patents FGFR-4 inhibitors
Read More
Angion Biomedica plans phase III trial of BB3 in delayed kidney graft function
Read More
Tonix Pharmaceuticals starts phase III trial of TNX-102 SL for fibromyalgia
Read More
Dicerna expands phase I trial of DCR-MYC to include PNET cohort
Read More
Discovery Labs' phase IIa study of Aerosurf meets key objectives
Read More
Luye Pharma completes three studies for risperidone extended-release microspheres
Read More
FDA grants fast track designation to TRC-105 for renal cell carcinoma
Read More
Xadago launched in Germany for mid- to late-stage Parkinson's disease
Read More
ISIS-664844 selectively targets the P23H variant of Rhodopsin
Read More
Vaccination with FSPs shows potential for the treatment of MSI-H CRC
Read More
FDA approves Treximet for use in pediatric migraine
Read More
Novartis reports development of complement factor B inhibitors
Read More
FORUM Pharmaceuticals patents nAChR alpha7 agonists
Read More
Chugai discloses DDR1 inhibitors
Read More
Taisho develops antibacterial hydroxamic acids
Read More
Boehringer Ingelheim exercises option for Pharmaxis drug candidate
Read More
Preliminary phase I trial results presented on DC vaccination therapy for AML
Read More
Selecta and Genethon to investigate technology enabling repeat dosing of gene therapies
Read More
Alnylam files for permission to start phase I/II trial of alpha1-antitrypsin RNAi therapeutic
Read More
Mitsubishi Tanabe files application in Japan for Remicade in Kawasaki disease
Read More
Sacituzumab govitecan awarded FDA fast track designation for NSCLC
Read More
Bristol-Myers Squibb's IPN-007 receives U.S. orphan status for progressive supranuclear palsy
Read More
Prostanoid EP2/3 agonist ONO-8055: a promising agent for underactive bladder
Read More